<DOC>
	<DOCNO>NCT00304447</DOCNO>
	<brief_summary>The purpose study evaluate effect corticosteroid frequency severity Mylotarg速 infusion-related adverse event , evaluate effect corticosteroid efficacy Mylotarg速 induce complete response ( CR ) complete response incomplete platelet recovery ( CRp ) one-month post treatment .</brief_summary>
	<brief_title>Study Evaluating Effect Corticosteroids Mylotarg速 Infusion-Related Adverse Events Patients With Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Gemtuzumab</mesh_term>
	<criteria>Patients CD33 positive , resistant relapse AML . Patients &gt; 18 year age . ECOG performance status 02 . Fever ( &gt; 38 ) , chill hypotension ( systolic BP &lt; 105mmHg ) 48 hour precede therapy . Use corticosteroid , diphenhydramine acetaminophen within 24 hour enrollment . Participation Mylotarg速 protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Leukemia</keyword>
	<keyword>Mylotarg</keyword>
	<keyword>Safety</keyword>
	<keyword>Adverse Events</keyword>
</DOC>